Ansell Limited (ANSLF)
- Previous Close
0.00 - Open
18.00 - Bid 18.13 x 40000
- Ask 22.86 x 42300
- Day's Range
18.00 - 18.00 - 52 Week Range
15.83 - 23.42 - Volume
100 - Avg. Volume
1 - Market Cap (intraday)
2.627B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
22.22 - EPS (TTM)
0.81 - Earnings Date --
- Forward Dividend & Yield 0.44 (1.87%)
- Ex-Dividend Date Feb 14, 2025
- 1y Target Est
--
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
www.ansell.comRecent News: ANSLF
View MorePerformance Overview: ANSLF
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ANSLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ANSLF
View MoreValuation Measures
Market Cap
2.98B
Enterprise Value
3.53B
Trailing P/E
28.73
Forward P/E
26.81
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.76
Price/Book (mrq)
1.79
Enterprise Value/Revenue
1.99
Enterprise Value/EBITDA
14.12
Financial Highlights
Profitability and Income Statement
Profit Margin
6.05%
Return on Assets (ttm)
5.28%
Return on Equity (ttm)
6.48%
Revenue (ttm)
1.85B
Net Income Avi to Common (ttm)
112.1M
Diluted EPS (ttm)
0.81
Balance Sheet and Cash Flow
Total Cash (mrq)
268.9M
Total Debt/Equity (mrq)
42.94%
Levered Free Cash Flow (ttm)
176.09M